Related Experiment Videos
[Multiresistant tuberculosis in Denmark 1993-1996]
1Lungemedicinsk klinik, Rigshospitalet, København.
Ugeskrift for Laeger
|June 11, 1998
Summary
Multidrug-resistant tuberculosis (MDR-TB) is a growing concern in wealthy nations due to patient non-compliance and underfunded health systems. While curable, MDR-TB treatment is lengthy and costly, with future cases likely to increase.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Context:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant challenge in developed countries.
- Contributing factors include patient non-compliance and health system underfunding.
- A study in Denmark (1993-1996) identified ten MDR-TB cases.
Purpose:
- To report on the incidence and characteristics of MDR-TB cases in Denmark.
- To highlight the challenges associated with treating MDR-TB.
- To project future trends in MDR-TB cases.
Summary:
- Ten cases of tuberculosis caused by multidrug-resistant Mycobacterium tuberculosis were observed in Denmark between 1993 and 1996.
- Nine patients acquired the infection abroad, while one developed MDR-TB during treatment in Denmark.
- Treatment is feasible but requires substantial time and financial resources.
Impact:
- MDR-TB treatment is expensive and prolonged, impacting healthcare budgets.
- Increased domestic MDR-TB cases are anticipated due to funding deficits in tuberculosis programs.
- Immigration patterns may also influence the future incidence of MDR-TB acquired abroad.